BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25882409)

  • 21. Metabonomics of newborn screening dried blood spot samples: a novel approach in the screening and diagnostics of inborn errors of metabolism.
    Dénes J; Szabó E; Robinette SL; Szatmári I; Szőnyi L; Kreuder JG; Rauterberg EW; Takáts Z
    Anal Chem; 2012 Nov; 84(22):10113-20. PubMed ID: 23094949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Untargeted Metabolomics Identifies Biomarkers for MCADD Neonates in Dried Blood Spots.
    Sebaa R; AlMogren M; Alseraty W; Abdel Rahman AM
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feature construction can improve diagnostic criteria for high-dimensional metabolic data in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency.
    Ho S; Lukacs Z; Hoffmann GF; Lindner M; Wetter T
    Clin Chem; 2007 Jul; 53(7):1330-7. PubMed ID: 17513288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population spectrum of ACADM genotypes correlated to biochemical phenotypes in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency.
    Maier EM; Liebl B; Röschinger W; Nennstiel-Ratzel U; Fingerhut R; Olgemöller B; Busch U; Krone N; v Kries R; Roscher AA
    Hum Mutat; 2005 May; 25(5):443-52. PubMed ID: 15832312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: performance improvement by monitoring a new ratio.
    Hall PL; Wittenauer A; Hagar A
    Mol Genet Metab; 2014 Dec; 113(4):274-7. PubMed ID: 25454677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical, biochemical and genetic analyses in two Korean patients with medium-chain acyl-CoA dehydrogenase deficiency.
    Woo HI; Park HD; Lee YW; Lee DH; Ki CS; Lee SY; Kim JW
    Korean J Lab Med; 2011 Jan; 31(1):54-60. PubMed ID: 21239873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective study of the medium-chain acyl-CoA dehydrogenase deficiency in Portugal.
    Ventura FV; Leandro P; Luz A; Rivera IA; Silva MF; Ramos R; Rocha H; Lopes A; Fonseca H; Gaspar A; Diogo L; Martins E; Leão-Teles E; Vilarinho L; Tavares de Almeida I
    Clin Genet; 2014 Jun; 85(6):555-61. PubMed ID: 23829193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic investigation of cultivated fibroblasts from patients with mitochondrial short-chain acyl-CoA dehydrogenase deficiency.
    Edhager AV; Stenbroen V; Nielsen NS; Bross P; Olsen RKJ; Gregersen N; Palmfeldt J
    Mol Genet Metab; 2014 Mar; 111(3):360-368. PubMed ID: 24485985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medium-chain acyl-CoA dehydrogenase deficiency associated with a novel splice mutation in the ACADM gene missed by newborn screening.
    Grünert SC; Wehrle A; Villavicencio-Lorini P; Lausch E; Vetter B; Schwab KO; Tucci S; Spiekerkoetter U
    BMC Med Genet; 2015 Jul; 16():56. PubMed ID: 26223887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medium-chain acyl-CoA dehydrogenase deficiency: Two novel ACADM mutations identified in a retrospective screening.
    Smon A; Groselj U; Debeljak M; Zerjav Tansek M; Bertok S; Avbelj Stefanija M; Trebusak Podkrajsek K; Battelino T; Repic Lampret B
    J Int Med Res; 2018 Apr; 46(4):1339-1348. PubMed ID: 29350094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disruption of redox homeostasis in cerebral cortex of developing rats by acylcarnitines accumulating in medium-chain acyl-CoA dehydrogenase deficiency.
    Tonin AM; Grings M; Knebel LA; Zanatta Â; Moura AP; Ribeiro CA; Leipnitz G; Wajner M
    Int J Dev Neurosci; 2012 Aug; 30(5):383-90. PubMed ID: 22472139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis of inborn errors of metabolism using tandem mass spectrometry and gas chromatography mass spectrometry].
    Han LS; Ye J; Qiu WJ; Gao XL; Wang Y; Jin J; Gu XF
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2122-6. PubMed ID: 19080473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medium-chain acyl-CoA deficiency: outlines from newborn screening, in silico predictions, and molecular studies.
    Catarzi S; Caciotti A; Thusberg J; Tonin R; Malvagia S; la Marca G; Pasquini E; Cavicchi C; Ferri L; Donati MA; Baronio F; Guerrini R; Mooney SD; Morrone A
    ScientificWorldJournal; 2013; 2013():625824. PubMed ID: 24294134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of plasma ghrelin in patients with medium-chain acyl-CoA dehydrogenase deficiency and glutaric aciduria type II.
    Akamizu T; Sakura N; Shigematsu Y; Tajima G; Ohtake A; Hosoda H; Iwakura H; Ariyasu H; Kangawa K
    Eur J Endocrinol; 2012 Feb; 166(2):235-40. PubMed ID: 22048973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotype and residual enzyme activity in medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Are predictions possible?
    Tucci S; Wagner C; Grünert SC; Matysiak U; Weinhold N; Klein J; Porta F; Spada M; Bordugo A; Rodella G; Furlan F; Sajeva A; Menni F; Spiekerkoetter U
    J Inherit Metab Dis; 2021 Jul; 44(4):916-925. PubMed ID: 33580884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of gene mutations of medium-chain acyl-coenzyme a dehydrogenase deficiency (MCADD) by next-generation sequencing in Henan, China.
    Tian Y; Zhu X; Lv S; Jia C; Zhang L; Ni M; Xu Y; Peng R; Liu S; Zhao D
    Clin Chim Acta; 2022 Nov; 536():155-161. PubMed ID: 36096209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France.
    Hamers FF; Rumeau-Pichon C
    BMC Pediatr; 2012 Jun; 12():60. PubMed ID: 22681855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Application of tandem mass spectrometry on the diagnosis of fatty acid oxidation disorders].
    Han LS; Ye J; Qiu WJ; Gao XL; Wang Y; Zhang YJ; Gu XF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):692-5. PubMed ID: 18067086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tandem mass spectrometry analysis and genetic diagnosis of neonates with fatty acid oxidation disorders in central and northern regions of Guangxi].
    Tan J; Chen D; Huang J; Chang R; Yan T; Cai R
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Nov; 36(11):1067-1072. PubMed ID: 31703127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychological functioning in children with medium chain acyl coenzyme a dehydrogenase deficiency (MCADD): the impact of early diagnosis and screening on outcome.
    Joy P; Black C; Rocca A; Haas M; Wilcken B
    Child Neuropsychol; 2009 Jan; 15(1):8-20. PubMed ID: 18608229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.